PubRank

Joachim Weis

Author PubWeight™ 141.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PML in a patient treated with fumaric acid. N Engl J Med 2013 3.87
2 Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003 2.95
3 MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006 2.77
4 Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst 2011 2.56
5 Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet 2005 2.38
6 Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005 2.37
7 Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 2010 2.25
8 Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol 2013 1.87
9 Repairing injured peripheral nerves: Bridging the gap. Prog Neurobiol 2010 1.77
10 IL-6 is required for glioma development in a mouse model. Oncogene 2004 1.74
11 Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med 2008 1.70
12 The small GTPase Rab7 controls the endosomal trafficking and neuritogenic signaling of the nerve growth factor receptor TrkA. J Neurosci 2005 1.69
13 Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 2005 1.67
14 A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet 2013 1.61
15 Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs. Crit Care Med 2012 1.53
16 Chronic augmentation of the parasympathetic tone to the atrioventricular node: a nonthoracotomy neurostimulation technique for ventricular rate control during atrial fibrillation. J Cardiovasc Electrophysiol 2009 1.51
17 Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. Am J Hum Genet 2007 1.50
18 Reducing the duration of 100% oxygen ventilation in the early reperfusion period after cardiopulmonary resuscitation decreases striatal brain damage. Resuscitation 2010 1.44
19 Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 2009 1.44
20 Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet 2010 1.42
21 Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. J Exp Med 2010 1.41
22 Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 2009 1.40
23 SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc Natl Acad Sci U S A 2009 1.39
24 SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome. Brain 2013 1.29
25 Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev Neurobiol 2007 1.29
26 Implantation and explantation of a wireless epiretinal retina implant device: observations during the EPIRET3 prospective clinical trial. Invest Ophthalmol Vis Sci 2009 1.21
27 Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J Clin Oncol 2006 1.20
28 Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 2010 1.17
29 Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet 2009 1.16
30 Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol 2006 1.16
31 Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer 2010 1.15
32 Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy. J Neurol 2013 1.14
33 Augmentation of left ventricular contractility by cardiac sympathetic neural stimulation. Circulation 2010 1.12
34 Post-mortem forensic neuroimaging: correlation of MSCT and MRI findings with autopsy results. Forensic Sci Int 2007 1.11
35 Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol Aging 2006 1.10
36 A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer 2013 1.10
37 Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am J Med Genet A 2007 1.09
38 Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol 2007 1.08
39 In vitro assessment of axonal growth using dorsal root ganglia explants in a novel three-dimensional collagen matrix. Tissue Eng 2007 1.07
40 Ablation of Dicer from murine Schwann cells increases their proliferation while blocking myelination. PLoS One 2010 1.07
41 Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury. BMC Neurol 2012 1.05
42 Differential endocytic sorting of p75NTR and TrkA in response to NGF: a role for late endosomes in TrkA trafficking. Mol Cell Neurosci 2005 1.02
43 Propofol: neuroprotection in an in vitro model of traumatic brain injury. Crit Care 2009 1.01
44 Diagnostic challenge and therapeutic dilemma in necrotizing myopathy. Neurology 2013 1.01
45 The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol 2009 1.01
46 Clinical and neuropathological study about the neurotization of the suprascapular nerve in obstetric brachial plexus lesions. J Brachial Plex Peripher Nerve Inj 2009 1.01
47 The role of microstructured and interconnected pore channels in a collagen-based nerve guide on axonal regeneration in peripheral nerves. Biomaterials 2011 1.01
48 Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. Nat Neurosci 2013 1.01
49 In vitro cell alignment obtained with a Schwann cell enriched microstructured nerve guide with longitudinal guidance channels. Biomaterials 2008 0.99
50 Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR. Oncogene 2005 0.99
51 Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int 2012 0.99
52 Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF. Eur J Cell Biol 2011 0.99
53 Acetylcholine as an age-dependent non-neuronal source in the heart. Auton Neurosci 2010 0.98
54 The dark side of the NGF family: neurotrophins in neoplasias. Brain Pathol 2006 0.98
55 New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations. PLoS One 2013 0.98
56 The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells Dev 2012 0.95
57 Obstetric brachial plexus palsy: treatment strategy, long-term results, and prognosis. Dtsch Arztebl Int 2009 0.94
58 Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov Disord 2009 0.92
59 Ataxia, intellectual disability, and ocular apraxia with cerebellar cysts: a new disease? Cerebellum 2014 0.91
60 Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma. J Neurosurg 2007 0.91
61 Point mutation tRNA(Ser(UCN)) in a child with hearing loss and myoclonus epilepsy. J Child Neurol 2006 0.91
62 Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy. PLoS Genet 2013 0.90
63 Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X. Brain 2011 0.90
64 Homozygous microdeletion of chromosome 4q11-q12 causes severe limb-girdle muscular dystrophy type 2E with joint hyperlaxity and contractures. Hum Mutat 2005 0.90
65 Use of diffusion-weighted magnetic resonance imaging in differentiating purulent brain processes from cystic brain tumors. J Neurosurg 2002 0.90
66 Postmortem multislice computed tomography and magnetic resonance imaging of odontoid fractures, atlantoaxial distractions and ascending medullary edema. Int J Legal Med 2005 0.89
67 Myopathy in Marinesco-Sjögren syndrome links endoplasmic reticulum chaperone dysfunction to nuclear envelope pathology. Acta Neuropathol 2013 0.89
68 Sedation using propofol induces similar diaphragm dysfunction and atrophy during spontaneous breathing and mechanical ventilation in rats. Anesthesiology 2014 0.89
69 Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy. J Neurol 2010 0.89
70 Primary intraventricular schwannomas. Clin Neurol Neurosurg 2009 0.89
71 Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages. J Neurosurg 2007 0.88
72 Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies. J Peripher Nerv Syst 2010 0.88
73 Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. J Mol Cell Cardiol 2008 0.88
74 Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas. Acta Neuropathol 2013 0.87
75 [Sound meditation in oncological rehabilitation--a pilot study of a receptive music therapy group using the monochord]. Forsch Komplementmed 2008 0.87
76 Neurotrophins and neurodegenerative diseases: receptors stuck in traffic? J Neuropathol Exp Neurol 2003 0.87
77 A role of nitric oxide in neurite outgrowth of neuroblastoma cells triggered by mevastatin or serum reduction. Neurosci Lett 2009 0.86
78 Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury. BMC Neurol 2010 0.86
79 [Chronic diseases, psychological distress and coping -- challenges for psychosocial care in medicine]. Psychother Psychosom Med Psychol 2003 0.86
80 GAD Antibodies as Key Link Between Chronic Intestinal Pseudoobstruction, Autonomic Neuropathy, and Limb Stiffness in a Nondiabetic Patient: A CARE-Compliant Case Report and Review of the Literature. Medicine (Baltimore) 2015 0.86
81 [Prevalence of affective and anxiety disorders in cancer: systematic literature review and meta-analysis]. Psychother Psychosom Med Psychol 2012 0.85
82 Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: involvement of mitochondria in tumor drug resistance? Tumour Biol 2011 0.85
83 Chronic electrical neuronal stimulation increases cardiac parasympathetic tone by eliciting neurotrophic effects. Circ Res 2011 0.84
84 Hydrogen sulfide does not increase resuscitability in a porcine model of prolonged cardiac arrest. Shock 2010 0.84
85 Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene. Acta Neuropathol 2008 0.83
86 Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines. J Neurooncol 2012 0.82
87 Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 2014 0.82
88 Histology of human glioblastoma transplanted on chicken chorioallantoic membrane. Medicina (Kaunas) 2009 0.82
89 Electrical stimulation of sympathetic neurons induces autocrine/paracrine effects of NGF mediated by TrkA. J Mol Cell Cardiol 2010 0.82
90 Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion. Cell Mol Neurobiol 2010 0.82
91 Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma. Am J Pathol 2005 0.82
92 The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients. Eur J Cancer 2012 0.82
93 Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene. Arch Neurol 2005 0.81
94 [Prevalence of adjustment disorder, acute and posttraumatic stress disorders as well as somatoform disorders in cancer patients]. Psychother Psychosom Med Psychol 2013 0.81
95 Early administration of xenon or isoflurane may not improve functional outcome and cerebral alterations in a porcine model of cardiac arrest. Resuscitation 2009 0.81
96 Novel FHL1 mutation in a family with reducing body myopathy. Muscle Nerve 2012 0.81
97 Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction. Neuromuscul Disord 2011 0.81
98 Differences in the surface binding and endocytosis of neurotrophins by p75NTR. Mol Cell Neurosci 2004 0.80
99 Developing a self-rating measure of patient competence in the context of oncology: a multi-center study. Psychooncology 2008 0.80
100 Neuropathology training worldwide-evolution and comparisons. Brain Pathol 2014 0.80
101 Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome. Muscle Nerve 2014 0.80
102 Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot-Marie- Tooth disease type 2E. Clin Neuropathol 2014 0.80
103 Mechanical stretch of sympathetic neurons induces VEGF expression via a NGF and CNTF signaling pathway. Biochem Biophys Res Commun 2011 0.80
104 Delayed argon administration provides robust protection against cardiac arrest-induced neurological damage. Neurocrit Care 2015 0.80
105 Differential effects of myopathy-associated caveolin-3 mutants on growth factor signaling. Am J Pathol 2010 0.79
106 Exon 17 skipping in CLCN1 leads to recessive myotonia congenita. Muscle Nerve 2004 0.79
107 The multifaceted character of lymphotoxin β in inflammatory myopathies and muscular dystrophies. Neuromuscul Disord 2012 0.79
108 Distribution of the NF-kappaB complex in the inflammatory exudates characterizing the idiopathic inflammatory myopathies. Ann N Y Acad Sci 2009 0.79
109 Case reports of PML in patients treated for psoriasis. N Engl J Med 2013 0.79
110 Neurocognitive performance after cardiopulmonary resuscitation in pigs. Crit Care Med 2008 0.79
111 Glycogenosome accumulation in the arrector pili muscle in Pompe disease. Orphanet J Rare Dis 2014 0.79
112 Mitochondrial abnormalities in myofibrillar myopathies. Clin Neuropathol 2014 0.79
113 Fetuin-a in the developing brain. Dev Neurobiol 2012 0.78
114 Twelve-Month and Lifetime Prevalence of Mental Disorders in Cancer Patients. Psychother Psychosom 2016 0.78
115 Prevalence of mental disorders, psychosocial distress and need for psychosocial support in cancer patients - study protocol of an epidemiological multi-center study. BMC Psychiatry 2012 0.78
116 A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. Ann N Y Acad Sci 2009 0.78
117 Perineurial cells filled with collagen in 'atypical' Cogan's syndrome. Acta Neuropathol 2007 0.78
118 Esthesioneuroblastoma of the pituitary gland: a clinicopathological entity? Case report and review of the literature. J Neurosurg 2004 0.78
119 Morphological spectrum and clinical features of myopathies with tubular aggregates. Histol Histopathol 2013 0.78
120 Repetitive intrathecal VEGF(165) treatment has limited therapeutic effects after spinal cord injury in the rat. J Neurotrauma 2010 0.78
121 Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest. Int J Cardiol 2012 0.78
122 Age-related regional differences in cardiac nerve growth factor expression. Age (Dordr) 2011 0.78
123 Modulation of hippocampal neuroplasticity by Fas/CD95 regulatory protein 2 (Faim2) in the course of bacterial meningitis. J Neuropathol Exp Neurol 2014 0.78
124 The Modified Glasgow Outcome Score for the prediction of outcome in patients after cardiac arrest: a prospective clinical proof of concept study. Clin Res Cardiol 2012 0.77
125 Rate and irregularity of electrical activation during atrial fibrillation affect myocardial NGF expression via different signalling routes. Cell Signal 2011 0.77
126 Prolonged mechanical ventilation alters the expression pattern of angio-neogenetic factors in a pre-clinical rat model. PLoS One 2013 0.77
127 Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL). Clin Neurol Neurosurg 2004 0.77
128 PLEKHG5 deficiency leads to an intermediate form of autosomal-recessive Charcot-Marie-Tooth disease. Hum Mol Genet 2013 0.77
129 SOX10 mutation with peripheral amyelination and developmental disturbance of axons. Muscle Nerve 2012 0.77
130 Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative. Eur J Cancer Care (Engl) 2009 0.77
131 Release of interleukin-6 via the regulated secretory pathway in PC12 cells. Neurosci Lett 2006 0.77
132 Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Rev Pharmacoecon Outcomes Res 2011 0.76
133 Differential pattern of neuroprotection in lumbar, cervical and thoracic spinal cord segments in an organotypic rat model of glutamate-induced excitotoxicity. J Chem Neuroanat 2013 0.76
134 Can in-vitro chemoresponse assays help find new treatment regimens for malignant gliomas? Anticancer Drugs 2014 0.76
135 Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3. Biol Chem 2005 0.76
136 Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p/19q status. Strahlenther Onkol 2007 0.75
137 Is xenon really neuroprotective after cardiac arrest? Anesthesiology 2006 0.75
138 Corrigendum: Transcriptional regulator PRDM12 is essential for human pain perception. Nat Genet 2015 0.75
139 [Music therapy in oncology--concepts and review]. Psychother Psychosom Med Psychol 2004 0.75
140 Myopathy with hexagonally cross-linked crystalloid inclusions: delineation of a clinico-pathological entity. Neuromuscul Disord 2010 0.75
141 Meningeal carcinomatosis: two unusual clinical, laboratory, and radiological presentations. Eur Neurol 2002 0.75
142 Psycho-oncology in a united Europe--changes and challenges. Crit Rev Oncol Hematol 2003 0.75
143 Myopathy with lobulated fibers, cores, and rods caused by a mutation in collagen VI. Neurology 2012 0.75
144 Accumulation of STIM1 is associated with the degenerative muscle fibre phenotype in ALS and other neurogenic atrophies. Neuropathol Appl Neurobiol 2015 0.75
145 [In Process Citation]. MMW Fortschr Med 2015 0.75
146 [Dance/movement therapy in oncological rehabilitation]. Forsch Komplementmed 2013 0.75
147 Near-fatal cerebellar swelling caused by acute multifocal cerebellar necrosis. Eur J Paediatr Neurol 2003 0.75
148 [Beweggründe von Krebspatienten für und gegen die Inanspruchnahme der Misteltherapie]. Forsch Komplementmed 2016 0.75
149 Early muscle and brain ultrastructural changes in polymerase gamma 1-related encephalomyopathy. Neuropathology 2012 0.75